Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Iovance Biotherapeutics (IOVA) over the last 14 years, with Q3 2025 value amounting to $9.8 million.

  • Iovance Biotherapeutics' Prepaid Assets changed N/A to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year change of. This contributed to the annual value of $12.4 million for FY2024, which is 2910.41% down from last year.
  • As of Q3 2025, Iovance Biotherapeutics' Prepaid Assets stood at $9.8 million.
  • In the past 5 years, Iovance Biotherapeutics' Prepaid Assets ranged from a high of $17.5 million in Q4 2023 and a low of $9.8 million during Q3 2025
  • Moreover, its 3-year median value for Prepaid Assets was $12.0 million (2023), whereas its average is $12.9 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first tumbled by 2910.41% in 2024, then surged by 3836.51% in 2025.
  • Quarter analysis of 3 years shows Iovance Biotherapeutics' Prepaid Assets stood at $17.5 million in 2023, then decreased by 29.1% to $12.4 million in 2024, then decreased by 20.68% to $9.8 million in 2025.
  • Its last three reported values are $9.8 million in Q3 2025, $11.5 million for Q2 2025, and $15.9 million during Q1 2025.